Clinical Trials Directory

Trials / Completed

CompletedNCT02213172

Evaluation of the Efficacy of Two Probiotic Strains for Irritable Bowel Syndrome

Evaluation of the Efficacy of Two Probiotic Strains for Irritable Bowel Syndrome: an 8-Week, Randomized, Placebo-Controlled Study

Status
Completed
Phase
Phase 2
Study type
Interventional
Enrollment
285 (actual)
Sponsor
KGK Science Inc. · Industry
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to determine if two different probiotic strains, Lactobacillus paracasei HA-196 and Bifidobacterium longum R0175, are effective in helping subjects manage the symptoms of IBS

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTBifidobacterium longum R0175
DIETARY_SUPPLEMENTLactobacillus paracasei HA-196
OTHERPlacebo

Timeline

Start date
2014-10-30
Primary completion
2018-02-15
Completion
2018-03-01
First posted
2014-08-11
Last updated
2020-03-13

Locations

1 site across 1 country: Canada

Source: ClinicalTrials.gov record NCT02213172. Inclusion in this directory is not an endorsement.